Back
Design Therapeutics Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
59
DSGN
Design Therapeutics
Last Price:
$5.31
Seasonality Move:
-20%
7 Day Trial
ALL ACCESS PASS
$
7
Design Therapeutics Stock Forecast
-
Over the next 52 weeks, Design Therapeutics has on average historically fallen by 22.3% based on the past 4 years of stock performance.
-
Design Therapeutics has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
-
Is Design Therapeutics Stock Undervalued?The current Design Therapeutics [DSGN] share price is $5.16. The Score for DSGN is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
DSGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Design Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Design Therapeutics has on average historically fallen by 22.3% based on the past 4 years of stock performance.
Design Therapeutics Stock Rating
Buy
59
Design Therapeutics (DSGN)
is a Buy
Is Design Therapeutics overpriced?
-
Design Therapeutics has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
Design Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
designtx.com
52-Week Data
52-Week High:
7.77
52-Week Low:
2.60
Prediction Charts
Market Cap:
302.1M
Price in USD:
5.16
Volume:
47K
Beta:
1.59
Technical Analysis
SMA50:
4.02
SMA100:
3.90
SMA200:
4.64
52-Wk Change:
22.27%
Stock Predictions
-
Is Design Therapeutics stock public?Yes, Design Therapeutics is a publicly traded company.
-
What is the Design Therapeutics stock quote today?The Design Therapeutics stock price is 5.16 USD today.
-
How to buy Design Therapeutics stock online?You can buy Design Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jul-28 | 4.05 | 4.04 | 4.16 | 3.95 |
| Jul-29 | 4.10 | 3.98 | 4.10 | 3.89 |
| Jul-30 | 4.02 | 4.03 | 4.19 | 3.98 |
| Jul-31 | 4.01 | 3.87 | 4.10 | 3.76 |
| Aug-1 | 3.81 | 3.82 | 3.92 | 3.77 |
| Aug-4 | 3.85 | 3.96 | 4.13 | 3.85 |
| Aug-5 | 3.92 | 4.06 | 4.13 | 3.90 |
| Aug-6 | 4.04 | 4.35 | 4.42 | 3.96 |
| Aug-7 | 4.35 | 3.97 | 4.35 | 3.95 |
| Aug-8 | 4.14 | 4.28 | 4.34 | 3.97 |
| Aug-11 | 4.28 | 4.82 | 4.86 | 4.23 |
| Aug-12 | 4.91 | 4.98 | 5.15 | 4.84 |
| Aug-13 | 5.01 | 5.42 | 5.48 | 5.01 |
| Aug-14 | 5.14 | 5.16 | 5.34 | 5.03 |
Design Therapeutics Earnings
Design Therapeutics Earnings Report: Per Share Design Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Design Therapeutics Forecast Revenue Growth
Design Therapeutics Stock Analysis: Historical quarterly revenues per share for Design Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.44 per share, and an increase next year of $0.12 per share.
* Design Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.